Respiratory syncytial virus – from discovery to vaccines

Escarlata López; Fausto M Ferolla; Patricio L. Acosta

doi:10.1099/jmm.0.002134

March 23, 2026Journal of Medical MicrobiologyOpen Access

Respiratory syncytial virus – from discovery to vaccines

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to explore the impact of respiratory syncytial virus on hospitalization and disease severity.
Analyzed historical data on RSV infections and hospitalizations
Reviewed key factors influencing susceptibility to RSV
Assessed vaccine development strategies for RSV
RSV is a leading cause of respiratory-related hospitalizations
Symptoms often mimic common cold, but can escalate to severe disease
Variability in disease severity indicates multiple influencing factors

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Examines RSV's impact on respiratory health and highlights vaccine development implications.

Abstract

Graphical Abstract Respiratory syncytial virus (RSV) is a leading respiratory cause of hospitalization. Symptoms are usually similar to those of the common cold, but in susceptible patients, RSV can cause severe disease and even death. The wide variation in response to RSV infection suggests that susceptibility and disease are influenced by multiple factors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

López et al. (2026) studied this question.

synapsesocial.com/papers/69c37bf3b34aaaeb1a67ee2e https://doi.org/10.1099/jmm.0.002134

View Full Paper

Ask AI

Bookmark

Share

Respiratory syncytial virus – from discovery to vaccines

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Respiratory syncytial virus – from discovery to vaccines

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading